Benicar and Ceftriaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benicar (olmesartan medoxomil) and Ceftriaxone (ceftriaxone sodium). Common drug interactions include metabolic acidosis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Benicar and Ceftriaxone. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

On Jul, 19, 2026

22 people who take Benicar and Ceftriaxone together, and have interactions are studied.

Benicar and Ceftriaxone drug interactions.

What are the common drug interactions of Benicar and Ceftriaxone, by gender? *:

female:

Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Muscle spasms (muscle contraction)
Nephrogenic anaemia (anaemia due to kidney disease)
Oedema peripheral (superficial swelling)
Pharyngeal mass
Pruritus (severe itching of the skin)
Renal failure chronic (long lasting kidney dysfunction)
Renal injury (kidney injury)
Sepsis (a severe blood infection that can lead to organ failure and death)
Yawning (simultaneous inhalation of air and stretching of the eardrums, followed by exhalation of breath)

male:

Pneumonia
Blood creatinine increased
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Haemorrhage (bleeding)
Rash
Renal haemorrhage (bleeding from kidney)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abdominal pain upper
Asthenia (weakness)

What are the common drug interactions of Benicar and Ceftriaxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Back pain
Renal failure (kidney dysfunction)
Chronic kidney disease
Agitation (state of anxiety or nervous excitement)
Blood creatine phosphokinase increased
Blood creatinine increased
Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
Confusional state
Dyskinesia (abnormality or impairment of voluntary movement)

60+:

Pneumonia
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Orthopnoea (shortness of breath (dyspnea) when lying down)
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Rash
Nausea (feeling of having an urge to vomit)
Abdominal pain upper
Asthenia (weakness)
Chronic kidney disease

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 40.91%
Depression: 6 people, 27.27%
High Blood Cholesterol: 5 people, 22.73%
Infection: 5 people, 22.73%
Pain: 5 people, 22.73%
Bacterial Infection: 4 people, 18.18%
Migraine (headache): 3 people, 13.64%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 13.64%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 13.64%
Weight Loss: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Benicar and Ceftriaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously